Is the tenofovir based therapy almighty for previous treatment failure in chronic hepatitis B?

Hyung Joon Yim

doi:10.3350/cmh.2016.0103

Is the tenofovir based therapy almighty for previous treatment failure in chronic hepatitis B?

Hyung Joon Yim

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English
Pages (from-to)	238-240
Number of pages	3
Journal	Clinical and Molecular Hepatology
Volume	22
Issue number	2
DOIs	https://doi.org/10.3350/cmh.2016.0103
Publication status	Published - 2016 Jun 1
Externally published	Yes

Keywords

Chronic hepatitis B
Resistance
Suboptimal
Tenofovir
Treatment failure

ASJC Scopus subject areas

Hepatology
Molecular Biology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.3350/cmh.2016.0103

Cite this

@article{b05d12478ddf413d9a72aa2b870dc815,

title = "Is the tenofovir based therapy almighty for previous treatment failure in chronic hepatitis B?",

keywords = "Chronic hepatitis B, Resistance, Suboptimal, Tenofovir, Treatment failure",

author = "Yim, {Hyung Joon}",

year = "2016",

month = jun,

day = "1",

doi = "10.3350/cmh.2016.0103",

language = "English",

volume = "22",

pages = "238--240",

journal = "Clinical and molecular hepatology",

issn = "2287-2728",